Enhance your practice with CME and tools that focus on the management of neurological conditions.
More Than a Myopathy: The Lived Experience of TK2d
ADHD Is Linked to a Broad Burden of GI Symptoms
What’s Still Missing in ADHD Care?
James Swanson, PhD
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Stroke-Like Symptoms During Treatment: Safety First
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Outcome Measures Capture Progression in Late-Onset TK2d
ADHD After 25 Years: What Have We Learned?
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Navigating the Limitations of Current BD Therapies
Antithrombotics and Amyloid Therapy: Balancing Risk
Recognizing ARIA Before Symptoms Appear
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.